(NasdaqGM:LGND), JUPITER, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) — Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) (“Ligand”) announced today the pricing of $400.0 million aggregate principal amount of 0.75% convertible senior notes due 2030 (the “notes”) in a private placement (the “offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the […]
Ligand Announces Pricing of $400 Million Convertible Senior Notes Offering GlobeNewswire August 12, 2025 JUPITER, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) — Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) (“Ligand”) announced today the pricing of $400.0 million aggregate principal amount of 0.75% convertible senior notes due 2030 (the “notes”) in a private placement (the “offering”) to persons
NEW YORK, NY / ACCESS Newswire / August 11, 2025 / If you suffered a loss on your Neogen Corporation (NASDAQ:NEOG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neogen-corporation-lawsuit-submission-form?prid=160966&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / August 11, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form-3?prid=160967&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
On August 11, 2025, Tingyi (Cayman Islands) Holding Corp. (0322.HK, the "Company", together with its subsidiaries, the "Group") is pleased to announce its interim results for the six months ended 30 June 2025. In the first half of 2025, the Group remained agile in identifying and capturing growth opportunities, while maintaining a disciplined focus on
NEW YORK, NY / ACCESS Newswire / August 11, 2025 / If you suffered a loss on your Flywire Corporation (NASDAQ:FLYW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/flywire-corporation-lawsuit-submission-form?prid=160965&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / August 11, 2025 / If you suffered a loss on your Hims & Hers Health, Inc. (NYSE:HIMS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/hims-hers-health-inc-lawsuit-submission-form?prid=160964&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq. via email at
NEW YORK, NY / ACCESS Newswire / August 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Marex Group plc ("Marex Group plc") (NASDAQ:MRX) concerning possible violations of federal securities laws. NINGI Research released a report alleging that Marex Group has concealed nearly $1 billion in off-balance-sheet derivatives exposure
NEW YORK, NY / ACCESS Newswire / August 11, 2025 / If you suffered a loss on your Lockheed Martin Corporation (NYSE:LMT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lockheed-martin-corporation-lawsuit-submission-form?prid=160963&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / August 11, 2025 / If you suffered a loss on your iRobot Corporation (NASDAQ:IRBT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irobot-corporation-lawsuit-submission-form?prid=160961&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call